Hoya Corporation, an optics and medical technology producer, has led part of a $15m financing round for Israel-based medical device developer 3NT Medical.
Venture capital fund LongTec China Ventures also participated in the tranche, which 3NT described as a major portion of the round, along with several undisclosed angel investors. The company has not revealed details of its earlier funding.
3NT is working on a device called the Sinusway Drivable Endoscope, a single-use endoscope that will help ear, nose and throat (ENT) doctors perform nasal surgery more effectively. The funding will support the completion of its development, and its commercialisation in the US and Europe.
Augustine Yee, Hoya’s chief legal officer and global head of corporate development, said: “Hoya’s investment in 3NT continues our commitment to partner with innovative medical device companies that align with our core strategic areas of interest.
“We are excited about 3NT’s disruptive visualisation technologies, and the benefits their devices will bring to ENT surgeons and their patients.”